Spectrum Pharmaceuticals Inc.
SPPI
NGS
Sector: Healthcare
Industry: Biotechnology
0.48
USD
0.04
(8.49%)
Optionable: Yes Market Cap: 83 M 90-day average vol: 4,575,586
Previous close: 0.4403 Open: 0.4484 Bid: 0.4776 Ask: 0.4776
52 week range
0.42 2.45
Last updated: Thursday 29th September 2022
Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS
Get started todaySearch for a stock
Are you?
Metrics
Valuation
Price per Sales TTM ($) | 0.00 |
Price per Book TTM ($) | 5.96 |
PE Ratio (TTM) | -1.50 |
Book Value per Share ($) | 0.18 |
5 Year PE Range-15.9 |
Returns
7 Day Return | -24.72% | |
1 Month Return | -58.10% | |
3 Month Return | -38.76% | |
1 Year Return | -79.41% | |
3 Year Return | -94.24% | |
5 Year Return | -96.60% | |
YTD Return | -62.39% |
Risk
Custom Beta One Year | 1.79 |
Custom Beta Three Years | 1.36 |
Beneish M Score | 0.00 |
Altman Z Score | -15.26 |
Analyst Estimates
Financial Health
Technicals
RSI (14 Day) | 25.41 |
14 Day SMA ($) | 0.85 |
14 Day EMA ($) | 0.75 |
Money Flow Index | 37.08 |
Average True Range | 0.12 |
50 Day SMA ($) | 1.04 |
200 Day SMA ($) | 0.97 |
ADX | 0.00 |
MACD | -0.18 |
Growth
Free Cash Flow QoQ Growth | -22.69% |
Free Cash Flow YoY Growth | 0.00% |
Revenue YoY Growth | 0.00% |
EPS QoQ Growth | 88.89% |
Revenue QoQ Growth | 0.00% |
EPS YoY Growth | 0.00% |
Profitability
News
Financials
SPPI Income Statement
Annual
| Dec-12 | Dec-13 | Dec-14 | Dec-15 | Dec-16 | Dec-17 | Dec-18 | Dec-19 | Dec-20 | Dec-21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 268 M | 156 M | 187 M | 163 M | 146 M | 0 | 0 | 0 | 0 | 0 |
| Cost of sales | 31 M | 4 M | 621000 | 2 M | 9 M | 19 M | -2 M | -1 M | -481000 | -679000 |
| Gross operating profit | 224 M | 129 M | 161 M | 128 M | 111 M | -47 M | -26 M | 0 | 0 | 0 |
| Selling Gen & administrative expense | 90 M | 99 M | 97 M | 88 M | 88 M | 65 M | 63 M | 61 M | 60 M | 60 M |
| Research & development expense | 42 M | 47 M | 70 M | 51 M | 59 M | 52 M | 75 M | 79 M | 109 M | 87 M |
| Operating income | 81 M | -39 M | -32 M | -43 M | -63 M | -116 M | -138 M | -141 M | -170 M | -148 M |
| floaterest income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| floaterest expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other income net | -359000 | 4 M | -3 M | -573000 | 238000 | 389000 | 10 M | -9 M | -3 M | -11 M |
| Pre-tax Income (EBT) | 80 M | -37 M | -44 M | -52 M | -72 M | -123 M | -129 M | -145 M | -171 M | -158 M |
| Income taxes | -14 M | 25 M | 2 M | 406000 | -2 M | -22 M | -2 M | -9 M | -60000 | 4000 |
| Net income from total operations | 94 M | -62 M | -46 M | -53 M | -70 M | -92 M | -121 M | -113 M | -161 M | -159 M |
| Minority floaterest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total net income | 94 M | -62 M | -46 M | -53 M | -70 M | -92 M | -121 M | -113 M | -161 M | -159 M |
| Preferred dividends | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net income available for common | 94 M | -62 M | -46 M | -53 M | -70 M | -101 M | -127 M | -135 M | -171 M | -158 M |
| Depreciation | 12 M | 22 M | 25 M | 32 M | 26 M | 28 M | 28 M | 1 M | 481000 | 679000 |
| Amortization | 9 M | 20 M | 24 M | 38 M | 26 M | 28 M | 28 M | 0 | 0 | 0 |
| Operating income before depreciation (EBITDA) | 93 M | -12 M | -10 M | -5 M | -36 M | -88 M | -100 M | -139 M | -169 M | -147 M |
| Total Income available for floaterest expense (EBIT) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Basic EPS total | 1.61 | -1.02 | -0.71 | -0.78 | -0.94 | -1.08 | -1.17 | -1.02 | -1.29 | -1.02 |
| Diluted EPS total | 1.46 | -1.02 | -0.71 | -0.78 | -0.94 | -1.08 | -1.17 | -1.02 | -1.29 | -1.02 |
Call: 1-877-778-8358
I am so happy you are here. My name is Ankur and I am the founder/CEO of MarketXLS. Over the past four years, I have helped more than 2500 customers to implement their own investment research strategies and monitoring systems in Excel.
Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONSGet started today